Under FSMA, the new rules now read that FDA can “order administrative detention if there is reason to believe that an article of food is adulterated or misbranded.”
FDA is seeking public comment on changes to criteria for detaining food at the point of import.
Enacted in January of this year, the Food Safety Modernization Act (FSMA) changed the administrative detention criteria originally bestowed on FDA by the Bioterrorism Act of 2002, which allowed the agency to “detain any article of food if, during an inspection, examination, or investigation, an FDA officer or qualified employee finds there is credible evidence or information indicating that the article of food presents a threat of serious adverse health consequences or death to humans or animals.”
Under FSMA, the new rules now read that FDA can “order administrative detention if there is reason to believe that an article of food is adulterated or misbranded.” Read Nutritional Outlook’s in-depth analysis on this change in wording here.
Dietary supplements are regulated as food in the United States. Thus, detention criteria also apply to this segment of the market.
FDA may detain food products for a maximum of 30 calendar days. Appeals can be filed, to which the agency must respond to within five calendar days. For more background on the rules, click here.
The agency has now released draft guidance, asking for public comment on the new detention rules.
Nutritional Outlook thanks Harry Rice, PhD, for the tip.
Driving Sustainability in Nutraceuticals: How Ingredient Brands Are Raising the Bar
April 26th 2024Health-minded consumers, especially Generation Z, value nutraceutical companies with sustainability embedded into their corporate philosophy—from product development to packaging. This article discusses how responsible companies are responding to the consumer call for greater sustainability by implementing environmentally friendly manufacturing practices that ultimately lead to waste reduction, improved supplier communications and lower supply chain risk. Those who have taken steps to demonstrate a genuine commitment to sustainability are standing out with improved outcomes for all.
The Nutritional Outlook Podcast Episode 29: 2024 Ingredients to Watch
January 31st 2024Nutritional Outlook interviews Scott Dicker, market insights director from market researcher SPINS, about ingredients and product categories nutraceutical and nutrition product manufacturers should watch in 2024.
Rousselot to showcase new collagen peptide research and targeted solutions at Vitafoods Europe 2024
April 25th 2024The company will be highlighting new research that demonstrates the ability of its Peptan collagen peptide brand to support sleep quality, reduce gastrointestinal discomfort, and enhance skin health, including density, hydration, and elasticity.